αν and β1 Integrins Mediate Aβ-Induced Neurotoxicity in Hippocampal Neurons via the FAK Signaling Pathway

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Han, Hai Yan ^a   Zhang, Jin Ping ^b   Ji, Su Qiong ^a   Liang, Qi Ming ^a   Kang, Hui Cong ^a   Tang, Rong Hua ^a   Zhu, Sui Qiang ^a   Xue, Zheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD51 ANTIGEN; FOCAL ADHESION KINASE; MICROTUBULE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA; AMYLOID BETA PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NEUROPROTECTIVE AGENT; NEUROTOXIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CELL VIABILITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HIPPOCAMPUS; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; VIRUS TITRATION; ANIMAL; APOPTOSIS; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LENTIVIRINAE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TOXICITY;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTIGENS, CD29; APOPTOSIS; CELL SURVIVAL; FLOW CYTOMETRY; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN SITU NICK-END LABELING; INTEGRIN ALPHAV; LENTIVIRUS; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PHOSPHORYLATION; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84878632917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064839     Document Type: Article

References (42)

1. Azizi Z, Noroozian M, Kaini-Moghaddam Z, Majlessi N, (2010) Association between NOS3 gene G8974T polymorphism and late-onset Alzheimer disease in a sample from Iran. Alzheimer Dis Assoc Disord 24(2): 204-208.
2. Selkoe DJ, (2002) Alzheimer's disease is a synaptic failure. Science 298(5594): 789-791.
3. Alzheimer's Association, (2012) Alzheimer's disease facts and figures. Alzheimers Dement 8(2): 131-168.
4. Wang PY, Chen JJ, Su HM, (2010) Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression. J Nutr Biochem 21(4): 345-350.
5. Annaert W, De Strooper B, (2002) A cell biological perspective on Alzheimer's disease. Annu Rev Cell Dev Biol 18: 25-51.
6. Lee FT, Mountain AJ, Kelly MP, Hall C, Rigopoulos A, et al. (2005) Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A"-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478. Clin Cancer Res 11(19 Pt 2): 7080s-7086s.
7. Hardy J, Selkoe DJ, (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580): 353-356.
8. Kelly BL, Ferreira A, (2007) Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience 147(1): 60-70.
9. Abdul HM, Calabrese V, Calvani M, Butterfield DA, (2006) Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J Neurosci Res 84(2): 398-408.
10. Yu QS, Reale M, Kamal MA, Holloway HW, Luo W, et al. (2013) Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-synuclein synthesis, interleukin-1β release, and cholinergic action. Antiinflamm Antiallergy Agents Med Chem [Epud ahead of print].
11. Verdier Y, Zarandi M, Penke B, (2004) Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J Pept Sci 10(5): 229-248.
12. Yu Y, He J, Zhang Y, Luo H, Zhu S, et al. (2009) Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model. Hippocampus 19(12): 1247-1253.
13. Aplin AE, (2003) Cell adhesion molecule regulation of nucleocytoplasmic trafficking. FEBS Lett 534(1-3): 11-14.
14. Schwartz MA, Assoian RK, (2001) Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 114(Pt 14): 2553-2560.
15. Juhász G, Vass G, Bozsó Z, Budai D, Penke B, et al. (2008) Integrin activation modulates NMDA and AMPA receptor function of CA1 cells in a dose-related fashion in vivo. Brain Res 1233: 20-26.
16. Wang Q, Klyubin I, Wright S, Griswold-Prenner I, Rowan MJ, et al. (2008) Alpha v integrins mediate beta-amyloid induced inhibition of long-term potentiation. Neurobiol Aging 29(10): 1485-1493.
17. Wright S, Malinin NL, Powell KA, Yednock T, Rydel RE, et al. (2007) Alpha2beta1 and alphaVbeta1 integrin signaling pathways mediate amyloid-beta-induced neurotoxicity. Neurobiol Aging 28(2): 226-237.
18. Lim M, Guccione S, Haddix T, Sims L, Cheshier S, et al. (2005) alpha(v)beta(3) Integrin in central nervous system tumors. Hum Pathol 36(6): 665-669.
19. Matter ML, Zhang Z, Nordstedt C, Ruoslahti E, (1998) The alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis. J Cell Biol 141(4): 1019-1030.
20. Creed MC, Milgram NW, (2010) Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications. Age (Dordr) 32(3): 365-384.
21. Rowan MJ, Klyubin I, Wang Q, Anwyl R, (2005) Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Biochem Soc Trans 33(Pt 4): 563-567.
22. Selkoe DJ, (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192(1): 106-113.
23. Takahashi RH, Capetillo-Zarate E, Lin MT, Milner TA, Gouras GK, (2010) Co-occurrence of Alzheimer's disease ß-amyloid and τ pathologies at synapses. Neurobiol Aging 31(7): 1145-1452.
24. van der Flier A, Sonnenberg A, (2001) Function and interactions of integrins. Cell Tissue Res 305(3): 285-298.
25. Hehlgans S, Haase M, Cordes N, (2007) Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta 1775(1): 163-180.
26. Leu ST, Jacques SA, Wingerd KL, Hikita ST, Tolhurst EC, et al. (2004) Integrin alpha4beta1 function is required for cell survival in developing retina. Dev Biol 276(2): 416-430.
27. Zhao-Yang Z, Ke-Sen X, Qing-Si H, Wei-Bo N, Jia-Yong W, et al. (2008) Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells. Cancer Lett 266(2): 209-215.
28. Luo M, Guan JL, (2010) Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 289(2): 127-139.
29. Jiang X, Sinnett-Smith J, Rozengurt E, (2007) Differential FAK phosphorylation at Ser-910, Ser-843 and Tyr-397 induced by angiotensin II, LPA and EGF in intestinal epithelial cells. Cell Signal 19(5): 1000-1010.
30. Ramjaun AR, Hodivala-Dilke K, (2009) The role of cell adhesion pathways in angiogenesis. Int J Biochem Cell Biol 41(3): 521-530.
31. Choi YA, Kim DK, Kang SS, Sonn JK, Jin EJ, (2009) Integrin signaling and cell spreading alterations by rottlerin treatment of chick limb bud mesenchymal cells. Biochimie 91(5): 624-631.
32. Gupta A, Dey CS, (2009) PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase. Mol Cell Endocrinol 309(1-2): 55-62.
33. Zhu J, Wang YS, Zhang J, Zhao W, Yang XM, et al. (2009) Focal adhesion kinase signaling pathway participates in the formation of choroidal neovascularization and regulates the proliferation and migration of choroidal microvascular endothelial cells by acting through HIF-1 and VEGF expression in RPE cells. Exp Eye Res 88(5): 910-918.
34. Monferran S, Skuli N, Delmas C, Favre G, Bonnet J, et al. (2008) Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer 123(2): 357-364.
35. Cordes N, Meineke V, (2004) Integrin signalling and the cellular response to ionizing radiation. J Mol Histol 35(3): 327-337.
36. Williamson R, Scales T, Clark BR, Gibb G, Reynolds CH, et al. (2002) Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J Neurosci 22(1): 10-20.
37. Zhang C, Lambert MP, Bunch C, Barber K, Wade WS, et al. (1994) Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide. J Biol Chem 269(41): 25247-25250.
38. Grace EA, Busciglio J, (2003) Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy. J Neurosci 23(2): 493-502.
39. Kasahara T, Koguchi E, Funakoshi M, Aizu-Yokota E, Sonoda Y, (2002) Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation. Antioxid Redox Signal 4(3): 491-499.
40. Golubovskaya V, Kaur A, Cance W, (2004) Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochim Biophys Acta 1678(2-3): 111-125.
41. Golubovskaya VM, Finch R, Cance WG, (2005) Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53. J Biol Chem 280(26): 25008-25021.
42. Richardson A, Malik RK, Hildebrand JD, Parsons JT, (1997) Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol Cell Biol 17(12): 6906-6914.